CytomX Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $-456.0K | $38.1M |
| FY2025 | — | $99.0M | $12.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | — | $-456.0K | $38.1M |
| FY2025 | — | $99.0M | $12.7M |